BTCC / BTCC Square / investopedia /
S&P 500 Today: Home Depot Earnings Slump Sends Stock Plunging While Medtronic Shares Soar

S&P 500 Today: Home Depot Earnings Slump Sends Stock Plunging While Medtronic Shares Soar

Published:
2025-11-18 21:14:07
4
2

S&P 500 Gains and Losses Today: Home Depot Slumps as Earnings Disappoint; Medtronic Stock Jumps

Wall Street's daily drama unfolds as earnings season delivers brutal verdicts

Home Depot's Disappointing Quarter

The home improvement giant stumbles hard—missing earnings targets and sending shareholders scrambling. Another reminder that even retail titans can't escape market gravity when quarterly numbers disappoint.

Medtronic's Surprise Surge

Meanwhile, medical device maker Medtronic defies expectations with a stunning rally. Proof that in today's market, one company's pain is another's double-digit gain.

The S&P 500's constant reshuffling continues—where yesterday's winners become today's tax loss harvesting opportunities. Because nothing says 'strategic portfolio management' like panic-selling during earnings season.

Key Takeaways

  • A home improvement retailer faced pressure on Tuesday, Nov. 18, 2025, as housing market headwinds weighed on earnings, while a medical device maker benefitted from strong demand.
  • Home Depot reported lower-than-expected quarterly earnings and trimmed its full-year forecast, sending its shares lower.
  • Medtronic shares advanced after the maker of medical devices surpassed quarterly estimates, highlighting strong demand across its end markets.

Shares of a major home improvement retailer lost ground after it missed quarterly profit forecasts, indicating homeowners are putting off remodeling projects amid economic uncertainty. Meanwhile, strong demand and procedure volumes helped drive a strong earnings report for a medical device company, and its shares advanced.

Major U.S. equities indexes dropped for the second straight day ahead of several high-profile earnings reports and the release of delayed jobs data due later this week. The S&P 500 dropped 0.8%, the Dow slid 1.1%, and the Nasdaq lost 1.2%. Click here for more reporting from Investopedia on Tuesday's financial markets. 

Home Depot (HD) stock tumbled 6% to log the worst performance in the S&P 500 after the home improvement retailer missed forecasts with its third-quarter earnings, noting that a lack of storms during the period weighed on its performance. The company also lowered its full-year profit forecast, citing persistent headwinds in the housing market and suggested that homeowners are pushing back remodeling projects amid broader economic uncertainty.

Concerns about high valuations for companies in the artificial intelligence space weighed on the tech sector. Shares of Western Digital (WDC), the hard disk drive Maker that has drawn attention from investors given its opportunity to help satiate AI's massive data storage needs, fell 5.9% Tuesday. Shares of memory chipmaker Micron Technology (MU) lost 5.6%.

Amazon (AMZN) and Microsoft (MSFT) shares slipped 4.4% and 2.7%, respectively, as regulators in the European Union announced that they were launching investigations into cloud computing services offered by the two tech giants.

The move lower for Microsoft stock also came as the software giant announced a partnership with AI startup Anthropic. Chipmaker Nvidia (NVDA) announced a deal with Anthropic as well. Nvidia shares slid close to 3% Tuesday ahead of the chipmaker's highly anticipated earnings release Wednesday afternoon.

Medtronic (MDT) stock advanced about 5% after the medical device maker topped analysts' estimates with its fiscal second-quarter sales and adjusted profit. The manufacturer of pacemakers and other cardiovascular devices also lifted its full-year forecast for organic revenue growth, highlighting strong procedure volumes and a positive demand picture across its end markets.

Merck (MRK) announced positive results from a Phase 2 trial of a key heart treatment, and shares of the pharmaceutical company jumped nearly 4%. In the study, Merck's Winrevair met its primary endpoints in helping patients with certain heart conditions reduce pulmonary hypertension, or high blood pressure in the blood vessels that supply the lungs.

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users

All articles reposted on this platform are sourced from public networks and are intended solely for the purpose of disseminating industry information. They do not represent any official stance of BTCC. All intellectual property rights belong to their original authors. If you believe any content infringes upon your rights or is suspected of copyright violation, please contact us at [email protected]. We will address the matter promptly and in accordance with applicable laws.BTCC makes no explicit or implied warranties regarding the accuracy, timeliness, or completeness of the republished information and assumes no direct or indirect liability for any consequences arising from reliance on such content. All materials are provided for industry research reference only and shall not be construed as investment, legal, or business advice. BTCC bears no legal responsibility for any actions taken based on the content provided herein.